Skip to main content

Potential Pro-Convulsive Properties of Ketamine and Its Effects on EEG During Procedural Sedation: a Comparative Evaluation with Midazolam and Propofol

The investigators evaluated the safety and potential pro-epileptic effects of intravenous (IV) ketamine during procedural sedation in comparison with IV midazolam and IV propofol. Specifically, the study hypothesizes that IV ketamine, at doses used for procedural sedation, exhibits pro-convulsive properties, lowers the epileptic seizure threshold, and may induce interictal epileptiform discharges and/or seizures. Additionally, the investigators assessed the effects of these sedative agents on electroencephalographic (EEG) activity during procedural sedation.

Status
completed
Phase
Phase 4
Institution
Haseki Training and Research Hospital
Start date
2024-12-01
End date
2025-08-30
Registry ID
NCT06741930

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.